A comprehensive view of neurological/cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck KGaA announces acquisition of Chord Therapeutics, a Swiss-based company focused on rare neuroinflammatory diseases; company's research includes focus on antibody-mediated disease
Published: December 20, 2021 by Merck KGaA
Biogen announces European Commission marketing authorization for orally administered VUMERITY for treatment of relapsing-remitting multiple sclerosis; drug was previously approved in the US, UK and Switzerland
Published: November 16, 2021 by European Commission
Pfizer and Biohaven Pharmaceutical Holding enter agreement for commercialization of rimegepant outside US; drug is commercialized as Nurtec ODT in the US, used for treatment of migraine attacks
Published: November 10, 2021 by Pfizer Inc.
Neurelis commences clinical study to assess use of VALTOCO diazepam nasal spray in children with epilepsy aged two-to-five years needing treatment for seizure clusters; drug currently approved in US for patients aged six years and above
Published: September 22, 2021 by Fitch Solutions Sector Intelligence
US EPA to end use of chlorpyrifos, a pesticide associated with neurological health problems, on all food products; due to its use on a range of food crops, a significant portion of people in the US reportedly have traces of chlorpyrifos in their bodies
Published: August 26, 2021 by Post Register

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count